GlassScriptPhysician profile
Luis Alberto Colon
NPI 1932847076
$1,383.76
in general payments reported to CMS, 2019-2025
12 companies · $718 in 2025
The $718 reported for 2025 was more than what 89% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $666 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $358.32 | 2025 | Tyvaso |
| Abbvie INC. | $304.93 | 2024-2025 | |
| Mylan Specialty L.P. | $125.00 | 2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $117.80 | 2024 | |
| Amgen INC. | $112.36 | 2024-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $101.63 | 2024 | Eliquis |
| Genzyme Corporation | $100.00 | 2024 | |
| Janssen Pharmaceuticals, INC | $80.00 | 2024 | Xarelto |
| Pbg Puerto Rico LLC | $33.55 | 2024-2025 | |
| Adc Therapeutics America, INC. | $23.45 | 2025 | |
| Scpharmaceuticals INC. | $19.23 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.49 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.